Jong P,Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enala- pril on 12-year survival and life expectancy in patients with left ventricu- lar systolic dysfunction: a follow-up study. Lancet. 2003;361:1843 1848. doi: 10.1016/S0140-6736(03)13501-5. 243. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: the SOLVD Investigators. N Engl J Med. 1992;327:685 691. 244. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): the CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429 1435. 245. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes V, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303 310. doi: 10.1056/NEJM199108013250502. 246. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD Investigators. N Engl J Med. 1991;325:293 302. 247. Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCENT Investigators. Effects of telmisartan, ramipril, and their combination on left ventricular hyper- trophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. Circulation. 2009;120:1380 1389. doi: 10.1161/CIRCULATIONAHA.109.865774. 248. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759 766. 249. Pfeffer MA, McMurray JJ,Velazquez EJ, Rouleau JL, K ber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ven- tricular dysfunction, or both. N Engl J Med. 2003;349:1893 1906. doi: 10.1056/NEJMoa032292. 250. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A ran- domized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667 1675. doi: 10.1056/ NEJMoa010713. 251. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin- converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772 776. doi: 10.1016/S0140-6736(03)14284-5. 252. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angioten- sin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767 771. doi: 10.1016/S0140-6736(03)14283-3. 253. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709 717. doi: 10.1056/ NEJM199909023411001. 254. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11 21. doi: 10.1056/NEJMoa1009492. 255. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implanta- tion of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877 883. doi: 10.1056/ NEJMoa013474. 256. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225 237. doi: 10.1056/NEJMoa043399. Kulik et al Secondary Prevention After CABG 959 257. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ven- tricular systolic dysfunction: a pooled analysis of 10 primary preven- tion trials. J Am Coll Cardiol. 2004;44:2166 2172. doi: 10.1016/j. jacc.2004.08.054. 258. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery: Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569 1575. doi: 10.1056/ NEJM199711273372201. 259. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22:1305 1313. 260. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283 e352. doi: 10.1161/CIR.0b013e318276ce9b. 261. Every NR, Fahrenbruch CE, Hallstrom AP, Weaver WD, Cobb LA. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol. 1992;19:1435 1439. 262. Autschbach R, Falk V, Gonska BD, Dalichau H. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recur- rent episodes after ICD implantation and review of literature. Pacing Clin Electrophysiol. 1994;17(pt 2):552 558. 263. Berntsen RF, Gunnes P, Lie M, Rasmussen K. Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia. Eur Heart J. 1993;14:1297 1303. 264. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140 2150. doi: 10.1056/ NEJMoa032423. 265. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchro- nization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539 1549. doi: 10.1056/NEJMoa050496. 266. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiac- resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329 1338. doi: 10.1056/NEJMoa0906431. 267. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild- to-moderate heart failure. N Engl J Med. 2010;363:2385 2395. doi: 10.1056/NEJMoa1009540. 268. Kim YG, Park DW, Lee WS, Park GM, Sun BJ, Lee CH, Hwang KW, Cho SW, Kim YR, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, KimYH, Lee CW, Park SW, Han S, Jung SH, Choo SJ, Chung CH, Lee JW, Park SJ. Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization. Am J Cardiol. 2012;109:1548 1557. doi: 10.1016/j.amjcard.2012.01.377. 269. American Diabetes Association. Standards of medical care in diabe- tes 2012. Diabetes Care. 2012;35(suppl 1):S11 S63. 270. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(suppl 1):S64 71. 271. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327 1334. 272. Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, Bridges CR, Haan CK, Svedjeholm R, Taegtmeyer H, Shemin RJ; Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663 669. doi: 10.1016/j.athoracsur.2008.11.011. 273. Frioud A, Comte-Perret S, Nguyen S, Berger MM, Ruchat P, Ruiz J. Blood glucose level on postoperative day 1 is predictive of adverse out- comes after cardiovascular surgery. Diabetes Metab. 2010;36:36 42. doi: 10.1016/j.diabet.2009.06.008. 274. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497 1502. doi: 10.1161/01. CIR.0000121747.71054.79. 275. Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg. 2011;254:458 463. doi: 10.1097/SLA.0b013e31822c5d78. 276. Desai SP, Henry LL, Holmes SD, Hunt SL, Martin CT, Hebsur S, Ad N. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. J Thorac Cardiovasc Surg. 2012;143:318 325. doi: 10.1016/j.jtcvs.2011.10.070. 277. Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, Ailawadi G. Superiority of moderate control of hyperglyce- mia to tight control in patients undergoing coronary artery bypass graft- ing. J Thorac Cardiovasc Surg. 2011;141:543 551. doi: 10.1016/j. jtcvs.2010.10.005. 278. Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, Glauber M, Kellett MA, Kramer RS, Leadley K, Dawkins KD, Serruys PW. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 1075. doi: 10.1016/j.jacc.2009.09.057. 279. Yilmaz MB, Guray Y, Guray U, Biyikoglu SF, Tandogan I, Korkmaz S. Metabolic syndrome increases the risk of significant coronary artery involvement in patients with peripheral artery disease. Coron Artery Dis. 2006;17:529 532. 280. Lorusso R, Pentiricci S, Raddino R, Scarabelli TM, Zambelli C, Villanacci V, Burattin A, Romanelli G, Casari S, Scelsi R, Giustina A. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes. 2003;52:2814 2820. 281. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248 258. 282. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, Thottapurathu L, Krasnicka B, Ellis N, Anderson RJ, Henderson W; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149 2156. doi: 10.1016/j.jacc.2004.08.064. 283. Parang P, Arora R. Coronary vein graft disease: pathogenesis and pre- vention. Can J Cardiol. 2009;25:e57 e62. 284. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study Research Group. Intensive diabetes treatment and car- diovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643 2653. doi: 10.1056/NEJMoa052187. 285. Effect of intensive blood-glucose control with metformin on com- plications in overweight patients with type 2 diabetes (UKPDS 34): UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854 865. 286. Intensive blood-glucose control with sulphonylureas or insulin com- pared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837 853. 287. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic con- trol and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119:351 357. doi: 10.1161/ CIRCULATIONAHA.108.191305. 288. World Health Organization. Report on the global tobacco epidemic 2008: the MPOWER package. http://www.who.int/tobacco/mpower_ report_full_2008.pdf. Accessed July 18, 2013. 289. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341 350. doi: 10.1056/NEJMsa1211128. 290. Al-Sarraf N, Thalib L, Hughes A, Tolan M, Young V, McGovern E. Effect of smoking on short-term outcome of patients undergoing coro- nary artery bypass surgery. Ann Thorac Surg. 2008;86:517 523. doi: 10.1016/j.athoracsur.2008.03.070. 291. Mortasawi A, Ashraf MN, Grayson AD, Oo AY. Impact of smoking on the results of coronary artery bypass surgery [in German]. Herz. 2004;29:310 316. doi: 10.1007/s00059-004-2573-5. 292. Steingrimsson S, Gottfredsson M, Kristinsson KG, Gudbjartsson T. Deep sternal wound infections following open heart surgery in Iceland: a population-based study. Scand Cardiovasc J. 2008;42:208 213. doi: 10.1080/14017430801919557. 293. Lindsay GM, Tolmie EP, Martin WM, Hutton IM, Belcher PR. Smoking after coronary artery bypass: high three-year mortality. Thorac Cardiovasc Surg. 2009;57:135 140. doi: 10.1055/s-2008-1039271. 294. Papathanasiou A, Milionis H, Toumpoulis I, Kalantzi K, Katsouras C, Pappas K, Michalis L, Goudevenos J. Smoking cessation is associated with reduced long-term mortality and the need for repeat interventions after coronary artery bypass grafting. Eur J Cardiovasc Prev Rehabil. 2007;14:448 450. doi: 10.1097/HJR.0b013e3280403c68. 295. van Domburg RT, Meeter K, van Berkel DF, Veldkamp RF, van Herwerden LA, Bogers AJ. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol. 2000;36:878 883. 296. Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass sur- gery: pathophysiology, management, and future directions. Ann Surg. 2013;257:824 833. doi: 10.1097/SLA.0b013e318288c38d. 297. Saxena A, Shan L, Reid C, Dinh DT, Smith JA, Shardey GC, Newcomb AE. Impact of smoking status on early and late outcomes after isolated coronary artery bypass graft surgery. J Cardiol. 2013;61:336 341. doi: 10.1016/j.jjcc.2013.01.002. 298. A clinical practice guideline for treating tobacco use and depen- dence: a US Public Health Service report: the Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000;283:3244 3254. 299. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interven- tions for hospitalized smokers: a systematic review. Arch Intern Med. 2008;168:1950 1960. doi: 10.1001/archinte.168.18.1950. 300. Gjeilo KH, Stenseth R, Klepstad P, Lydersen S, Wahba A. Patterns of smoking behaviour in patients following cardiac surgery: a prospective study. Scand Cardiovasc J. 2010;44:295 300. doi: 10.3109/14017431.2010.500395. 301. Barth J, Critchley J, Bengel J. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev. 2008:CD006886. 302. Rigotti NA, Clair C, Munaf MR, Stead LF. Interventions for smok- ing cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;5:CD001837. doi: 10.1002/14651858.CD001837.pub3. 303. Lindson N, Aveyard P, Hughes JR. Reduction versus abrupt ces- sation in smokers who want to quit. Cochrane Database Syst Rev. 2010:CD008033. 304. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessa- tion intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233 239. 305. Fiore MC, Ja n CR. A clinical blueprint to accelerate the elimina- tion of tobacco use. JAMA. 2008;299:2083 2085. doi: 10.1001/ jama.299.17.2083. 306. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scien- tific review. Circulation. 2014;129:1972 1986. doi: 10.1161/ CIRCULATIONAHA.114.007667. 307. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Antonnucio DO, Hartman N, McGovern PG. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335:1792 1798. doi: 10.1056/NEJM199612123352402. 308. Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and effec- tiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol. 2005;95:976 978. doi: 10.1016/j. amjcard.2004.12.039. 309. Paciullo CA, Short MR, Steinke DT, Jennings HR. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery. Ann Pharmacother. 2009;43:1197 1202. doi: 10.1345/aph.1L423. 310. Eisenberg MJ, Grandi SM, Gervais A, O Loughlin J, Paradis G, Rinfret S, Sarrafzadegan N, Sharma S, Lauzon C, Yadav R, Pilote L; ZESCA Investigators. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial. J Am Coll Cardiol. 2013;61:524 532. doi: 10.1016/j.jacc.2012.08.1030. 311. Planer D, Lev I, Elitzur Y, Sharon N, Ouzan E, Pugatsch T, Chasid M, Rom M, Lotan C. Bupropion for smoking cessation in patients with acute coronary syndrome. Arch Intern Med. 2011;171:1055 1060. doi: 10.1001/archinternmed.2011.72. 312. Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multi- centre, randomised study. Eur Heart J. 2003;24:946 955. 313. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56 63. doi: 10.1001/jama.296.1.56. 314. Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K. Efficacy and safety of the novel selective nic- otinic acetylcholine receptor partial agonist, varenicline, for smok- ing cessation. Arch Intern Med. 2006;166:1571 1577. doi: 10.1001/ archinte.166.15.1571. 315. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121:221 229. doi: 10.1161/CIRCULATIONAHA.109.869008. 316. Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med. 2008;148:554 556. 317. Hansen D, Dendale P, Leenders M, Berger J, Raskin A, Vaes J, Meeusen R. Reduction of cardiovascular event rate: different effects of cardiac rehabilitation in CABG and PCI patients. Acta Cardiol. 2009;64:639 644. 318. Hedb ck B, Perk J, H rnblad M, Ohlsson U. Cardiac rehabilitation after coronary artery bypass surgery: 10-year results on mortality, morbidity and readmissions to hospital. J Cardiovasc Risk. 2001;8:153 158. 319. Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;54:25 33. doi: 10.1016/j.jacc.2009.01.078. 320. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2001:CD001800. 321. Taylor RS, BrownA, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta- analysis of randomized controlled trials. Am J Med. 2004;116:682 692. doi: 10.1016/j.amjmed.2004.01.009. 322. Ades PA. Cardiac rehabilitation and secondary prevention of coro- nary heart disease. N Engl J Med. 2001;345:892 902. doi: 10.1056/ NEJMra001529. 323. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2005;111:369 376. doi: 10.1161/01.CIR.0000151788.08740.5C. 324. Pl ss CE, Billing E, Held C, Henriksson P, Kiessling A, Karlsson MR, Wallen HN. Long-term effects of an expanded cardiac rehabilita- tion programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study. Clin Rehabil. 2011;25:79 87. doi: 10.1177/0269215510376006. Kulik et al Secondary Prevention After CABG 961 325. Sethi PS, Nance J, Johnson D, Wilke J, Wilson K, Hall R, Romero- Vagedes F, Wilson C, Jones W, Dye D, Dzurick J, Ohm J, Ericson P, Wendel C, Mohler J, Dahiya R, Dick E, Thai H, Goldman S, Rhenman B, Morrison DA. A comprehensive cardiac rehabilitation program in post-CABG patients: a rationale and critical pathway. Crit Pathw Cardiol. 2003;2:20 33. doi: 10.1097/01.HPC.0000057391.93352.AA. 326. Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myo- cardial infarction among elderly Medicare beneficiaries. Circulation. 2010;121:63 70. doi: 10.1161/CIRCULATIONAHA.109.876383. 327. Thomas RJ, King M, Lui K, Oldridge N, Pina IL, Spertus J. AACVPR/ ACCF/AHA 2010 update: performance measures on cardiac rehabilita- tion for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/ American Heart Association Task Force on Performance Measures (Writing Committee to Develop Clinical Performance Measures for Cardiac Rehabilitation). Circulation. 2010;122:1342 1350. 328. Certo CM. History of cardiac rehabilitation. Phys Ther. 1985;65:1793 1795. 329. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, Franklin B, Sanderson B, Southard D. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scien- tific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2007;115:2675 2682. doi: 10.1161/ CIRCULATIONAHA.106.180945. 330. Martin BJ, Hauer T, Arena R, Austford LD, Galbraith PD, Lewin AM, Knudtson ML, Ghali WA, Stone JA,Aggarwal SG. Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation. 2012;126:677 687. doi: 10.1161/CIRCULATIONAHA.111.066738. 331. Cort s O, Arthur HM. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review. Am Heart J. 2006;151:249 256. doi: 10.1016/j.ahj.2005.03.034. 332. Brown TM, Hernandez AF, Bittner V, Cannon CP, Ellrodt G, Liang L, Peterson ED, Pi a IL, Safford MM, Fonarow GC; American Heart Association Get With The Guidelines Investigators. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association s Get With The Guidelines Program. J Am Coll Cardiol. 2009;54:515 521. doi: 10.1016/j.jacc.2009.02.080. 333. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116:1653 1662. doi: 10.1161/CIRCULATIONAHA.107.701466. 334. Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, Tomaselli GF, Yancy CW; American Heart Association Science Advisory and Coordinating Committee. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation. 2011;124:2951 2960. doi: 10.1161/ CIR.0b013e31823b21e2. 335. Dankner R, Geulayov G, Ziv A, Novikov I, Goldbourt U, Drory Y. The effect of an educational intervention on coronary artery bypass graft surgery patients participation rate in cardiac rehabilitation programs: a controlled health care trial. BMC Cardiovasc Disord. 2011;11:60. doi: 10.1186/1471-2261-11-60. 336. Gravely-Witte S, Leung YW, Nariani R, Tamim H, Oh P, Chan VM, Grace SL. Effects of cardiac rehabilitation referral strategies on refer- ral and enrollment rates. Nat Rev Cardiol. 2010;7:87 96. doi: 10.1038/ nrcardio.2009.223. 337. Grace SL, Russell KL, Reid RD, Oh P, Anand S, Rush J, Williamson K, Gupta M, Alter DA, Stewart DE; Cardiac Rehabilitation Care Continuity Through Automatic Referral Evaluation (CRCARE) Investigators. Effect of cardiac rehabilitation referral strategies on utilization rates: a prospective, controlled study. Arch Intern Med. 2011;171:235 241. doi: 10.1001/archinternmed.2010.501. 338. Eder B, Hofmann P, von Duvillard SP, Brandt D, Schmid JP, Pokan R, Wonisch M. Early 4-week cardiac rehabilitation exercise train- ing in elderly patients after heart surgery. J Cardiopulm Rehabil Prev. 2010;30:85 92. doi: 10.1097/HCR.0b013e3181be7e32. 339. Harkness K, Smith KM, Taraba L, Mackenzie CL, Gunn E, Arthur HM. Effect of a postoperative telephone intervention on attendance at intake for cardiac rehabilitation after coronary artery bypass graft surgery. Heart Lung. 2005;34:179 186. 340. Pack QR, Mansour M, Barboza JS, Hibner BA, Mahan MG, Ehrman JK, Vanzant MA, Schairer JR, Keteyian SJ. An early appointment to out- patient cardiac rehabilitation at hospital discharge improves attendance at orientation: a randomized, single-blind, controlled trial. Circulation. 2013;127:349 355. doi: 10.1161/CIRCULATIONAHA.112.121996. 341. Grace SL, Gravely-Witte S, Brual J, Suskin N, Higginson L, Alter D, Stewart DE. Contribution of patient and physician factors to cardiac rehabilitation referral: a prospective multilevel study. Nat Clin Pract Cardiovasc Med. 2008;5:653 662. doi: 10.1038/ncpcardio1272. 342. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring acti- vation in patients and consumers. Health Serv Res. 2004;39(pt 1):1005 1026. doi: 10.1111/j.1475-6773.2004.00269.x. 343. Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42:1443 1463. doi: 10.1111/j.1475-6773.2006.00669.x. 344. Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage. 2007;30:21 29. 345. Remmers C, Hibbard J, Mosen DM, Wagenfield M, Hoye RE, Jones C. Is patient activation associated with future health outcomes and health- care utilization among patients with diabetes? J Ambul Care Manage. 2009;32:320 327. doi: 10.1097/JAC.0b013e3181ba6e77. 346. Hibbard JH, Greene J, Tusler M. Improving the outcomes of disease management by tailoring care to the patient s level of activation. Am J Manag Care. 2009;15:353 360. 347. Beckie TM. A behavior change intervention for women in cardiac reha- bilitation. J Cardiovasc Nurs. 2006;21:146 153. 348. Fix GM, Bokhour BG. Understanding the context of patient expe- riences in order to explore adherence to secondary prevention guidelines after heart surgery. Chronic Illn. 2012;8:265 277. doi: 10.1177/1742395312441037. 349. Blanchard CM, Reid RD, Morrin LI, McDonnell L, McGannon K, Rhodes RE, Spence JC, Edwards N. Demographic and clinical determi- nants of moderate to vigorous physical activity during home-based car- diac rehabilitation: the Home-Based Determinants of Exercise (HOME) study. J Cardiopulm Rehabil Prev. 2010;30:240 245. doi: 10.1097/ HCR.0b013e3181d0c4ae. 350. Griffo R, Ambrosetti M, Tramarin R, Fattirolli F, Temporelli PL, Vestri AR, De Feo S, Tavazzi L; ICAROS Investigators. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modifi- cation and medication: results of the ICAROS Survey. Int J Cardiol. 2013;167:1390 1395. doi: 10.1016/j.ijcard.2012.04.069. 351. Moore SM, Kramer FM. Women s and men s preferences for car- diac rehabilitation program features. J Cardiopulm Rehabil. 1996;16:163 168. 352. Todaro JF, Shen BJ, Niaura R, Tilkemeier PL. Prevalence of depres- sive disorders in men and women enrolled in cardiac rehabilitation. J Cardiopulm Rehabil. 2005;25:71 75; quiz 76. 353. Moore SM, Dolansky MA, Ruland CM, Pashkow FJ, Blackburn GG. Predictors of women s exercise maintenance after cardiac rehabilitation. J Cardiopulm Rehabil. 2003;23:40 49. 354. Schuster PM, Wright C, Tomich P. Gender differences in the outcomes of participants in home programs compared to those in structured car- diac rehabilitation programs. Rehabil Nurs. 1995;20:93 101. 355. Eshah NF. Jordanian acute coronary syndrome patients learn- ing needs: implications for cardiac rehabilitation and second- ary prevention programs. Nurs Health Sci. 2011;13:238 245. doi: 10.1111/j.1442-2018.2011.00608.x. 356. Squires RW, Montero-Gomez A, Allison TG, Thomas RJ. Long-term disease management of patients with coronary disease by cardiac reha- bilitation program staff. J Cardiopulm Rehabil Prev. 2008;28:180 186; quiz 187 188. doi: 10.1097/01.HCR.0000320068.35728.12. 357. Moore SM, Charvat JM. Using the CHANGE intervention to enhance long-term exercise. Nurs Clin North Am. 2002;37:273 283, vi vii. 358. Parry MJ, Watt-Watson J, Hodnett E, Tranmer J, Dennis CL, Brooks D. Cardiac Home Education and Support Trial (CHEST): a pilot study. Can J Cardiol. 2009;25:e393 e398. 359. Leemrijse CJ, van Dijk L, J rstad HT, Peters RJ, Veenhof C. The effects of Hartcoach, a life style intervention provided by telephone on the reduction of coronary risk factors: a randomised trial. BMC Cardiovasc Disord. 2012;12:47. doi: 10.1186/1471-2261-12-47. 360. Scholz U, Knoll N, Sniehotta FF, Schwarzer R. Physical activity and depressive symptoms in cardiac rehabilitation: long-term effects of a self-management intervention. Soc Sci Med. 2006;62:3109 3120. doi: 10.1016/j.socscimed.2005.11.035. 361. Gallagher R, McKinley S. Anxiety, depression and perceived con- trol in patients having coronary artery bypass grafts. J Adv Nurs. 2009;65:2386 2396. doi: 10.1111/j.1365-2648.2009.05101.x. 362. Martin F. Recognizing depression after a coronary artery bypass graft. Br J Nurs. 2006;15:703 706. 363. Goyal TM, Idler EL, Krause TJ, Contrada RJ. Quality of life follow- ing cardiac surgery: impact of the severity and course of depressive symptoms. Psychosom Med. 2005;67:759 765. doi: 10.1097/01. psy.0000174046.40566.80. 364. Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB, Jones R, Mathew JP, Newman MF; NORG Investigators. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet. 2003;362:604 609. doi: 10.1016/S0140-6736(03)14190-6. 365. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet. 2001;358:1766 1771. doi: 10.1016/S0140-6736(01)06803-9. 366. Freedland KE, Skala JA, Carney RM, Rubin EH, Lustman PJ, D vila- Rom nVG, Steinmeyer BC, Hogue CW Jr. Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry. 2009;66:387 396. doi: 10.1001/archgenpsychiatry.2009.7. 367. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, Kapoor WN, Schulberg HC, Reynolds CF 3rd. Telephone- delivered collaborative care for treating post-CABG depression: a ran- domized controlled trial. JAMA. 2009;302:2095 2103. doi: 10.1001/ jama.2009.1670. 368. Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF. The effects of a tailored cardiac rehabilitation program on depressive symp- toms in women: a randomized clinical trial. Int J Nurs Stud. 2011;48:3 12. doi: 10.1016/j.ijnurstu.2010.06.005. 369. Dao TK, Youssef NA, Armsworth M, Wear E, Papathopoulos KN, Gopaldas R. Randomized controlled trial of brief cognitive behav- ioral intervention for depression and anxiety symptoms preopera- tively in patients undergoing coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2011;142:e109 e115. doi: 10.1016/j. jtcvs.2011.02.046. 370. Chocron S, Vandel P, Durst C, Laluc F, Kaili D, Chocron M, Etievent JP. Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial. Ann Thorac Surg. 2013;95:1609 1618. doi: 10.1016/j.athoracsur.2013.02.035. 371. Jensen B , Rasmussen LS, Steinbr chel DA. Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coro- nary artery bypass grafting: a randomized trial. Eur J Cardiothorac Surg. 2008;34:1016 1021. doi: 10.1016/j.ejcts.2008.07.053. 372. Andrew MJ, Baker RA, Bennetts J, Kneebone AC, Knight JL. A com- parison of neuropsychologic deficits after extracardiac and intracardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:9 14. 373. Fearn SJ, Pole R, Wesnes K, Faragher EB, Hooper TL, McCollum CN. Cerebral injury during cardiopulmonary bypass: emboli impair mem- ory. J Thorac Cardiovasc Surg. 2001;121:1150 1160. doi: 10.1067/ mtc.2001.114099. 374. Raymond PD, Hinton-Bayre AD, Radel M, Ray MJ, Marsh NA. Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery. Eur J Cardiothorac Surg. 2006;29:82 88. doi: 10.1016/j.ejcts.2005.10.016. 375. Selnes OA, Goldsborough MA, Borowicz LM Jr, Enger C, Quaskey SA, McKhann GM. Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem. Ann Thorac Surg. 1999;67:1669 1676. 376. Selnes OA, Pham L, Zeger S, McKhann GM. Defining cognitive change after CABG: decline versus normal variability. Ann Thorac Surg. 2006;82:388 390. doi: 10.1016/j.athoracsur.2006.02.060. 377. Rosengart TK, Sweet JJ, Finnin E, Wolfe P, Cashy J, Hahn E, Marymont J, Sanborn T. Stable cognition after coronary artery bypass grafting: comparisons with percutaneous intervention and normal controls. Ann Thorac Surg. 2006;82:597 607. doi: 10.1016/j.athoracsur.2006.03.026. 378. Sweet JJ, Finnin E, Wolfe PL, Beaumont JL, Hahn E, Marymont J, Sanborn T, Rosengart TK. Absence of cognitive decline one year after coronary bypass surgery: comparison to nonsurgical and healthy controls. Ann Thorac Surg. 2008;85:1571 1578. doi: 10.1016/j. athoracsur.2008.01.090. 379. Selnes OA, Grega MA, Borowicz LM Jr, Royall RM, McKhann GM, Baumgartner WA. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgi- cal controls. Ann Thorac Surg. 2003;75:1377 1384. 380. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocogni- tive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395 402. doi: 10.1056/NEJM200102083440601. 381. Stygall J, Newman SP, Fitzgerald G, Steed L, Mulligan K, Arrowsmith JE, Pugsley W, Humphries S, Harrison MJ. Cognitive change 5 years after coronary artery bypass surgery. Health Psychol. 2003;22:579 586. doi: 10.1037/0278-6133.22.6.579. 382. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM. Cognition 6 years after surgical or medical ther- apy for coronary artery disease. Ann Neurol. 2008;63:581 590. doi: 10.1002/ana.21382. 383. Johnson T, Monk T, Rasmussen LS, Abildstrom H, Houx P, Korttila K, Kuipers HM, Hanning CD, Siersma VD, Kristensen D, Canet J, Iba az MT, Moller JT; ISPOCD2 Investigators. Postoperative cognitive dys- function in middle-aged patients. Anesthesiology. 2002;96:1351 1357. 384. Rasmussen LS, Moller JT. Central nervous system dysfunction after anesthesia in the geriatric patient. Anesthesiol Clin North America. 2000;18:59 70, vi. 385. Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008;108:18 30. doi: 10.1097/01. anes.0000296071.19434.1e. 386. Ho PM, Arciniegas DB, Grigsby J, McCarthy M Jr, McDonald GO, Moritz TE, Shroyer AL, Sethi GK, Henderson WG, London MJ, VillaNueva CB, Grover FL, Hammermeister KE. Predictors of cogni- tive decline following coronary artery bypass graft surgery. Ann Thorac Surg. 2004;77:597 603. doi: 10.1016/S0003-4975(03)01358-4. 387. Goto T, Baba T, Honma K, Shibata Y, Arai Y, Uozumi H, Okuda T. Magnetic resonance imaging findings and postoperative neurologic dys- function in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2001;72:137 142. 388. Van Dijk D, Jansen EW, Hijman R, Nierich AP, Diephuis JC, Moons KG, Lahpor JR, Borst C, Keizer AM, Nathoe HM, Grobbee DE, De Jaegere PP, Kalkman CJ; Octopus Study Group. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a ran- domized trial. JAMA. 2002;287:1405 1412. 389. Marasco SF, Sharwood LN, Abramson MJ. No improvement in neuro- cognitive outcomes after off-pump versus on-pump coronary revascu- larisation: a meta-analysis. Eur J Cardiothorac Surg. 2008;33:961 970. doi: 10.1016/j.ejcts.2008.03.022. 390. van Dijk D, Spoor M, Hijman R, Nathoe HM, Borst C, Jansen EW, Grobbee DE, de Jaegere PP, Kalkman CJ; Octopus Study Group. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007;297:701 708. doi: 10.1001/jama.297.7.701. 391. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Vaijyanath P, Reddy SK, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Pogue J, Chrolavicius S,Yusuf S; CORONARY Investigators. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368:1179 1188. doi: 10.1056/NEJMoa1301228. 392. Eckel RH, Krauss RM. American Heart Association call to action: obe- sity as a major risk factor for coronary heart disease: AHA Nutrition Committee. Circulation. 1998;97:2099 2100. 393. Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34:791 799. doi: 10.1038/ijo.2010.5. 394. Romero-Corral A, Somers VK, Sierra-Johnson J, Jensen MD, Thomas RJ, Squires RW, Allison TG, Korinek J, Lopez-Jimenez F. Diagnostic performance of body mass index to detect obesity in patients with coro- nary artery disease. Eur Heart J. 2007;28:2087 2093. doi: 10.1093/ eurheartj/ehm243. 395. Coutinho T, Goel K, Corr a de S D, Carter RE, Hodge DO, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, Lorgis L, Lee SH, Kim YJ, Thomas R, Roger VL, Somers VK, Kulik et al Secondary Prevention After CABG 963 Lopez-Jimenez F. Combining body mass index with measures of cen- tral obesity in the assessment of mortality in subjects with coronary disease: role of normal weight central obesity. J Am Coll Cardiol. 2013;61:553 560. doi: 10.1016/j.jacc.2012.10.035. 396. Coutinho T, Goel K, Corr a de S D, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, Lorgis L, Lee SH, Kim YJ, Thomas R, Roger VL, Somers VK, Lopez-Jimenez F. Central obesity and survival in subjects with coronary artery disease: a system- atic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57:1877 1886. doi: 10.1016/j. jacc.2010.11.058. 397. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syn- drome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640 1645. doi: 10.1161/ CIRCULATIONAHA.109.192644. 398. Angeloni E, Melina G, Benedetto U, Refice S, Capuano F, Roscitano A, Comito C, Sinatra R. Metabolic syndrome affects midterm outcome after coronary artery bypass grafting. Ann Thorac Surg. 2012;93:537 544. doi: 10.1016/j.athoracsur.2011.10.066. 399. Echahidi N, Pibarot P, Despr s JP, Daigle JM, Mohty D, Voisine P, Baillot R, Mathieu P. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol. 2007;50:843 851. doi: 10.1016/j.jacc.2007.04.075. 400. Echahidi N, Mohty D, Pibarot P, Despr s JP, O Hara G, Champagne J, Philippon F, Daleau P, Voisine P, Mathieu P. Obesity and metabolic syn- drome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation. 2007;116(suppl):I213 I219. doi: 10.1161/CIRCULATIONAHA.106.681304. 401. Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O Hara G, Despr s JP, Mathieu P. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J. 2009;30:1270 1278. doi: 10.1093/eurheartj/ehp091. 402. Yilmaz MB, Guray U, Guray Y, Biyikoglu SF, Tandogan I, Sasmaz H, Korkmaz S. Metabolic syndrome negatively impacts early patency of saphenous vein grafts. Coron Artery Dis. 2006;17:41 44. 403. Kocz R, Hassan MA, Perala PR, Negargar S, Javadzadegan H, Nader ND. The effect of weight loss on the outcome after coronary artery bypass grafting in obese patients. Ann Card Anaesth. 2012;15:190 198. doi: 10.4103/0971-9784.97975. 404. Sierra-Johnson J, Wright SR, Lopez-Jimenez F, Allison TG. Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol. 2005;96:211 214. doi: 10.1016/j. amjcard.2005.03.046. 405. Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Brekke L, Lopez-Jimenez F. Effect of weight loss on predicted car- diovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring). 2007;15:772 784. doi: 10.1038/oby.2007.589. 406. Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, McCullough PA, Ren Fielding C, Franklin BA; on behalf of the American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123:1683 1701. doi: 10.1161/ CIR.0b013e3182149099. 407. Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML, Sarr MG, Somers VK. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc. 2005;80:1157 1162. doi: 10.4065/80.9.1157. 408. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med. 1997;336:1117 1124. doi: 10.1056/NEJM199704173361601. 409. Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Lopez-Jimenez F. Effect of bariatric surgery on the metabolic syn- drome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83:897 907. doi: 10.4065/83.8.897. 410. Chermesh I, Hajos J, Mashiach T, Bozhko M, Shani L, Nir RR, Bolotin G. Malnutrition in cardiac surgery: food for thought. Eur J Prev Cardiol. 2014;21:475 483. doi: 10.1177/2047487312452969. 411. Engelman DT, Adams DH, Byrne JG, Aranki SF, Collins JJ Jr, Couper GS, Allred EN, Cohn LH, Rizzo RJ. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118:866 873. 412. Rapp-Kesek D, St hle E, Karlsson TT. Body mass index and albumin in the preoperative evaluation of cardiac surgery patients. Clin Nutr. 2004;23:1398 1404. doi: 10.1016/j.clnu.2004.06.006. 413. DiMaria-Ghalili RA. Changes in nutritional status and postoperative outcomes in elderly CABG patients. Biol Res Nurs. 2002;4:73 84. 414. DiMaria-Ghalili RA. Changes in body mass index and late postopera- tive outcomes in elderly coronary bypass grafting patients: a follow-up study. Biol Res Nurs. 2004;6:24 36. doi: 10.1177/1099800404264538. 415. van Venrooij LM, van Leeuwen PA, de Vos R, Borgmeijer-Hoelen MM, de Mol BA. Preoperative protein and energy intake and postoperative complications in well-nourished, non-hospitalized elderly cardiac surgery patients. Clin Nutr. 2009;28:117 121. doi: 10.1016/j.clnu.2009.01.016. 416. Racca V, Castiglioni P, Ripamonti V, Bertoli S, Calvo MG, Ferratini M. Nutrition markers in patients after heart surgery. JPEN J Parenter Enteral Nutr. 2010;34:143 150. doi: 10.1177/0148607109357627. 417. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, Willett WC. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol. 2003;42:246 252. 418. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary dis- ease in women. N Engl J Med. 1993;328:1444 1449. doi: 10.1056/ NEJM199305203282003. 419. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians Health Study II randomized controlled trial. JAMA. 2008;300:2123 2133. doi: 10.1001/jama.2008.600. 420. Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, Gaziano JM. Multivitamins in the prevention of cardiovascular disease in men: the Physicians Health Study II randomized controlled trial. JAMA. 2012;308:1751 1760. doi: 10.1001/jama.2012.14805. 421. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group; Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, SleightP,PetoR,CollinsR.Effectsofhomocysteine-loweringwithfolicacid plus vitamin B12 vs placebo on mortality and major morbidity in myocar- dial infarction survivors: a randomized trial. JAMA. 2010;303:2486 2494. 422. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, B naa KH, Spence JD, Nyg rd O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R; B-Vitamin Treatment Trialists Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta- analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med. 2010;170:1622 1631. doi: 10.1001/archinternmed.2010.348. 423. Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, Park BJ; Korean Meta-Analysis Study Group. Efficacy of vitamin and antioxidant sup- plements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;346:f10. 424. Mickle DA, Weisel RD, Burton GW, Ingold KU. Effect of orally admin- istered alpha-tocopheryl acetate on human myocardial alpha-tocopherol levels. Cardiovasc Drugs Ther. 1991;5(suppl 2):309 312. 425. Yau TM, Weisel RD, Mickle DA, Burton GW, Ingold KU, Ivanov J, Mohabeer MK, Tumiati L, Carson S. Vitamin E for coronary bypass operations: a prospective, double-blind, randomized trial. J Thorac Cardiovasc Surg. 1994;108:302 310. 426. Pyles LA, Fortney JE, Kudlak JJ, Gustafson RA, Einzig S. Plasma anti- oxidant depletion after cardiopulmonary bypass in operations for con- genital heart disease. J Thorac Cardiovasc Surg. 1995;110:165 171. 427. Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D. Blood vitamin concentrations during the acute-phase response. Crit Care Med. 1992;20:934 941. 428. Schindler R, Berndt S, Schroeder P, Oster O, Rave G, Sievers HH. Plasma vitamin E and A changes during cardiopulmonary bypass and in the postoperative course. Langenbecks Arch Surg. 2003;387:372 378. doi: 10.1007/s00423-002-0336-4. 429. Storti S, CerilloAG, RizzaA, Giannelli I, Fontani G, Glauber M, Clerico A. Coronary artery bypass grafting surgery is associated with a marked reduction in serum homocysteine and folate levels in the early postoper- ative period. Eur J Cardiothorac Surg. 2004;26:682 686. doi: 10.1016/j. ejcts.2004.06.001. 430. Donnino MW, Cocchi MN, Smithline H, Carney E, Chou PP, Salciccioli J, Salciccoli J. Coronary artery bypass graft surgery depletes plasma thiamine levels. Nutrition. 2010;26:133 136. doi: 10.1016/j. nut.2009.06.004. 431. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, B rgermann J. Vitamin D status and the risk of major adverse cardiac and cerebrovas- cular events in cardiac surgery. Eur Heart J. 2013;34:1358 1364. doi: 10.1093/eurheartj/ehs468. 432. Armaganijan L, Lopes RD, Healey JS, Piccini JP, Nair GM, Morillo CA. Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials. Clinics (Sao Paulo). 2011;66:1923 1928. 433. He Z, Yang L, Tian J, Yang K, Wu J, Yao Y. Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis. Can J Cardiol. 2013;29:196 203. doi: 10.1016/j. cjca.2012.03.019. 434. Rasoli S, Kourliouros A, Harling L, Athanasiou T. Does prophylactic therapy with antioxidant vitamins have an effect on atrial fibrillation fol- lowing cardiac surgery? Interact Cardiovasc Thorac Surg. 2011;13:82 85. doi: 10.1510/icvts.2011.268326. 435. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and car- diovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310:1711 1720. doi: 10.1001/jama.2013.279206. 436. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease: a possible trigger for acute myocardial infarction? Int J Epidemiol. 1978;7:231 239. 437. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778 784. doi: 10.1056/NEJM199409223311206. 438. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccina- tion. N Engl J Med. 2004;351:2611 2618. doi: 10.1056/NEJMoa041747. 439. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601 610. doi: 10.1016/ S1473-3099(09)70233-6. 440. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myo- cardial infarction. Circulation. 2000;102:3039 3045. 441. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac dis- ease and stroke among the elderly. N Engl J Med. 2003;348:1322 1332. doi: 10.1056/NEJMoa025028. 442. Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, Gao Z, Katelaris AL, Siu HW, Lo V, Lindley R, Dwyer DE. Ischaemic heart disease, influenza and influenza vaccination: a prospec- tive case control study. Heart. 2013;99:1843 1848. doi: 10.1136/ heartjnl-2013-304320. 443. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous cor- onary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation. 2002;105:2143 2147. 444. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccina- tion in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J. 2004;25:25 31. 445. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W. Influenza vaccination in secondary prevention from coronary isch- aemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29:1350 1358. doi: 10.1093/eurheartj/ehm581. 446. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardio- vascular events in patients with acute coronary syndrome. Eur Heart J. 2011;32:1730 1735. doi: 10.1093/eurheartj/ehr004. 447. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM; American Heart Association; American College of Cardiology. Influenza vaccination as secondary preven- tion for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation. 2006;114:1549 1553. doi: 10.1161/CIRCULATIONAHA.106.178242. 448. Kuehn BM. CDC advisory committee recommends nearly univer- sal influenza vaccination. JAMA. 2010;303:1136. doi: 10.1001/ jama.2010.294. 449. Markewitz A, Faist E, Lang S, H ltner L, Weinhold C, Reichart B. An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg. 1996;10:61 67. 450. Franke A, Lante W, Kurig E, Z ller LG, Weinhold C, Markewitz A. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Eur J Cardiothorac Surg. 2006;30:64 71. doi: 10.1016/j.ejcts.2006.03.029. Key Words: AHA Scientific Statements coronary artery bypass grafting prevention and control risk-reduction behavior